What You Should Know:
- Amboy Street Ventures, the world's first venture capital firm focused on women's health and sexual health for all genders, closed its debut $20 million fund.
- Amboy Street plans to invest in the Seed and Series A stages of women’s health and sexual health startups to both lift associated stigmas and usher forward a new world of inclusive health and wellbeing.
Investment Thesis & Portfolio
The world is undergoing a massive social reformation
Read More
microbiome
Biomica Raises $20M to Advance its Pipeline of Microbiome-based Therapeutics
What You Should Know:
- Biomica, a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd raises $20M led by Shanghai Healthcare Capital (SHC).
- The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics. Biomica plans to use the proceeds to complete its current BMC128 phase 1 immuno-oncology study and advance to phase 2 clinical trial; scale up and complete GMP
Read More
Viome Raises $67M to Expand Microbiome & At-Home Test Kits
What You Should Know:
- Viome Life Sciences, a mission-driven digital health company, announced additional $67M in funding toward its Series C round.
- Led by Bold Capital Group, the $67M raise brings the company’s total funding to over $150M and will be used to support the development of its at-home tests that leverage precision nutrition to improve health and increase longevity by addressing the epidemic of chronic diseases, cancers, and aging.
- Viome will expand its proprietary mRNA
Read More
Digestive Health Market Map: Spectrum from Wellness to Chronic
Much like mental health, sexual health, and other conditions with social stigma, digestive health disorders cause many to suffer in silence. Only recently has society embraced a more public discussion of digestive health, ranging from wellness and performance to clinical prevention and chronic care management.
A confluence of social acceptance, innovation, and worsening public health are key driving forces for a broad array of emerging technology companies entering the category.
Read More
Seed Health Acquires Auggi’s Stool Recognition AI Tech & Algorithms
What You Should Know:
- Seed Healthv, a microbial sciences company, announced the acquisition of Auggi, a digital health company with a suite of artificial intelligence and machine learning technologies to track and analyze digestive health.
- As part of the acquisition, Seed Health will acquire Auggi's technology assets, including its AI algorithm for real-time Bristol stool typing, the world's largest stool image database, and a mobile monitoring application for clinical research.
-
Read More
Sun Genomics Nabs $8.65M to Scale Personalized Probiotic Solutions
What You Should Know:
- Sun Genomics raises $8.65M in Series A funding to scale
direct to consumer personalized probiotic solutions based on whole-genome sequencing
diagnostics.
- Flagship product Floré, a microbiome test, and gut probiotics solution utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles.
Sun Genomics, a San
Diego, CA-based
Read More
Sun Genomics and DexaFit Partner to Integrate Gut Health Testing
- Sun Genomics partners with DexaFit to integrate gut health testing to offer microbiome analysis and insights at 27 health and wellness clinics nationwide. - With the addition of Sun Genomics Floré testing, DexaFit is now incorporating microbiome analysis into its approach to give its clients a thorough understanding of their gut DNA or microbiome to further measure and improve their overall health and performance. Sun Genomics today announced that it is partnering with DexaFit, the
Read More
Sun Genomics Delivers Personalized Probiotics In Only 6 Weeks to Address Gut Health Issues
- Sun Genomics launches personalized probiotic solution to identify and address individual gut health issues to improve the health of millions of Americans. - Solution delivers precise probiotic formula required for each person to address their own unique gut health issues in just six weeks. - Sun Genomics Floré includes a kit to collect a micro-stool sample, a full microbiome analysis report, and a 90-day supply of precision probiotics.Sun Genomics today launched the first customized
Read More
BiomeSense Nabs $2M to Expand Daily Gut Microbiome Tracking Platform
- BiomeSense raises $2M in seed funding to expand its biosensor and analytics platform for daily gut microbiome tracking. - The company is working on completing its prototype biosensor and data modeling platform in preparation for the first clinical trials, scheduled for 2020.- The trials will investigate cancer progression, immunotherapy response, surgical recovery and athletic performance.BiomeSense, a Chicago, IL-based microbiome startup developing a novel biosensor and analytics platform for
Read More
Mayo Clinic to Leverage Viome’s Microbiome Analysis Platform in Study to Help Understand Sleep and Obesity
Mayo Clinic is collaborating on a study with Viome, a company transforming health through personalized nutrition based on individual biology to better understand the role of nutrition in disease and to explore the potential of Viome's AI-driven personalized diets in helping manage sleep disorders such as sleep apnea and obesity.
Understanding Microbiome
A person’s microbiome is the entire collection of microbes living in and on the body. The microbiome forms a living layer over your skin
Read More
